Diethylene glycol (DEG) residue testing with a validated limit of quantification (LOQ) is a critical safety control for glycerin, propylene glycol, and other glycol-based materials used in pharmaceuticals, foods, cosmetics, and consumer products. Accredited third-party laboratories apply gas chromatography methods (GC-FID and GC-MS) validated in accordance with ICH Q2(R2) to quantify DEG down to low mg/kg (ppm) levels. This article explains the technical principles of DEG LOQ determination, applicable standards, sample types, analytical workflows, and practical answers to frequently asked questions.
Technical Overview
Diethylene glycol (DEG, CAS 111-46-6) is a hygroscopic, water-miscible organic solvent with the molecular formula C4H10O3 and a molecular weight of 106.12 g/mol. It is generated as a co-product in the hydration of ethylene oxide and may enter the supply chain as a contaminant or adulterant in incompletely refined glycerin, propylene glycol, and low-molecular-weight polyethylene glycols. Human exposure to DEG is associated with severe health risks, including central nervous system depression, metabolic acidosis, hepatotoxicity, and acute kidney injury caused by toxic metabolites such as diglycolic acid. Historical poisoning incidents linked to DEG-contaminated excipients have made routine DEG screening a mandatory element of pharmaceutical and consumer product safety programs worldwide.
The limit of quantification (LOQ) is the lowest concentration of an analyte that can be quantitatively measured with acceptable accuracy and precision. For DEG residue testing, the LOQ must be set well below the applicable specification limit—commonly not more than 0.1% w/w (1000 mg/kg) for DEG and related glycols under pharmacopoeial monographs such as USP and Ph. Eur.—so that pass/fail decisions are statistically reliable and low-level contamination trends can be detected early. Many manufacturers apply internal action limits of 50 to 100 mg/kg or tighter, which demands analytical methods with LOQs at the low ppm level. Method validation and LOQ establishment follow the principles of ICH Q2(R2), and testing is typically performed in laboratories accredited to ISO/IEC 17025.
Testing Samples
Pharmaceutical Excipients and Raw Materials
Excipient-grade glycerin (glycerol), propylene glycol, polyethylene glycol grades (PEG 200, 300, 400, 600), sorbitol solutions, and maltitol solutions are the highest-risk materials because DEG contamination originates primarily at the bulk glycol production stage. Incoming raw material lots are typically screened against pharmacopoeial limits before release into production.
Finished Pharmaceutical Products
Oral solutions, cough syrups, elixirs, suspensions, topical gels, creams, and suppositories containing glycerin- or glycol-based vehicles are tested to confirm that no DEG was introduced through raw materials, carryover, or packaging interactions. Finished product testing requires matrix-specific method validation because sugars, preservatives, and co-solvents can interfere with chromatographic determination.
Food Products and Ingredients
Food-grade glycerin (E422), humectants used in confectionery and baked goods, flavor and fragrance carriers, and beverage formulations are tested to verify compliance with food safety requirements and supplier specifications at mg/kg levels.
Cosmetics and Personal Care Products
Toothpaste, mouthwash, skin creams, lotions, and other leave-on or rinse-off products containing glycerin are screened for DEG contamination, supporting compliance with cosmetic safety regulations and trace contaminant restrictions.
Consumer and Industrial Products
Electronic cigarette and vapor liquids based on propylene glycol and vegetable glycerin blends, toy materials such as finger paints covered by the EN 71 toy safety framework, antifreeze formulations, and polyester resin intermediates may also require DEG residue determination.
Testing Items
The scope of a DEG residue testing program typically includes the following items, each reported with full traceability to validated methods:
- Quantitative determination of DEG content, expressed in mg/kg (ppm) or % w/w
- Determination and verification of the method limit of detection (LOD) and limit of quantification (LOQ)
- Co-determination of related glycols, including ethylene glycol (EG) and triethylene glycol (TEG), in a single chromatographic run
- Method validation parameters per ICH Q2(R2): specificity, linearity, range, accuracy (recovery), precision (repeatability and intermediate precision), and robustness
- Conformity assessment against specification limits, such as the pharmacopoeial limit of not more than 0.1% w/w for DEG-related impurities
- Reporting of results with measurement uncertainty, calibration traceability, and system suitability data
Testing Methods
Sample Preparation
Samples are accurately weighed and diluted gravimetrically in a suitable solvent such as methanol, water, or a water-methanol mixture. An internal standard—commonly 1,3-butanediol or a similar glycol not expected in the sample—is added to correct for injection variability and matrix effects. Matrix-matched calibration standards covering the range from the LOQ level to above the specification limit are prepared for quantitative work. High-viscosity matrices such as neat glycerin require careful homogenization and dilution to ensure representative sub-sampling.
GC-FID Analysis
Gas chromatography with flame ionization detection (GC-FID) is the compendial workhorse technique, aligned with the chromatographic approaches described in USP and Ph. Eur. monographs for glycerin and related glycols. Separation is achieved on a medium-polarity capillary column with split injection, and DEG is quantified against the internal standard. Typical LOQs for DEG in glycerin matrices by GC-FID are in the range of approximately 5 to 50 mg/kg, providing a substantial margin below the 1000 mg/kg pharmacopoeial limit.
GC-MS Confirmation
Gas chromatography with mass spectrometric detection (GC-MS) in selected-ion monitoring mode offers superior selectivity for complex matrices and enables lower quantification limits, typically in the range of 0.5 to 5 mg/kg. Characteristic fragment ions are monitored with qualifier ion ratios to confirm identity, which is essential when investigating low-level contamination, resolving co-eluting interferences, or verifying results from screening methods. GC-MS confirmation is recommended for out-of-specification investigations and for products with very tight internal action limits.
LOQ Determination and Verification
The LOQ is established in accordance with ICH Q2(R2) using one or more of the following approaches:
- Signal-to-noise approach: the LOQ corresponds to a signal-to-noise ratio of approximately 10:1, whereas the LOD corresponds to approximately 3:1
- Calibration curve approach: LOQ is calculated as 10 times the residual standard deviation of the response divided by the calibration slope
- Matrix-spiked verification: replicate preparations of blank matrix spiked at the proposed LOQ level must demonstrate precision (relative standard deviation typically within 10% to 20%) and accuracy (recovery typically 80% to 120%)
- Documented confirmation through multiple independent sequences, analysts, and instruments where required by the validation protocol
Quality Control and System Suitability
Each analytical sequence includes system suitability criteria such as resolution between DEG and adjacent glycol peaks, replicate injection precision, calibration linearity (typically r not less than 0.995), internal standard recovery, and bracketing calibration verification standards. Independent reference materials and control charts are maintained under an ISO/IEC 17025 quality system to ensure long-term data integrity and comparability between batches.
Applications
DEG residue testing with a documented LOQ supports a wide range of quality, safety, and regulatory activities across multiple industries:
- Excipient supplier qualification and incoming material release testing for pharmaceutical manufacturers
- Batch release testing and out-of-specification investigations for oral liquid and topical pharmaceutical products
- Detection of economically motivated adulteration of glycerin and propylene glycol in the supply chain
- Regulatory submissions and compendial compliance demonstrations aligned with USP, Ph. Eur., ChP, and ICH expectations
- Food additive and cosmetic ingredient safety verification against mg/kg-level specifications
- Screening of e-liquids and consumer products, including toy-related materials within the EN 71 framework
- Research and method development for new formulations, novel excipients, and packaging compatibility studies
FAQ
What LOQ can typically be achieved for DEG residue testing?
With GC-FID, LOQs of approximately 5 to 50 mg/kg are routinely achievable in glycerin-based matrices. GC-MS methods can reach approximately 0.5 to 5 mg/kg. Both approaches provide a large margin below the common pharmacopoeial limit of 1000 mg/kg (0.1% w/w), and the appropriate technique is selected based on the product specification and matrix complexity.
How is the LOQ different from the LOD?
The limit of detection (LOD) is the lowest amount of analyte that can be reliably detected but not necessarily quantified accurately, corresponding to a signal-to-noise ratio of approximately 3:1. The limit of quantification (LOQ) is the lowest amount that can be quantified with acceptable accuracy and precision, corresponding to a signal-to-noise ratio of approximately 10:1. Only results at or above the LOQ should be used for quantitative compliance decisions.
Why is a low LOQ important when the regulatory limit is 0.1%?
A low LOQ ensures that contamination is detected long before it approaches the specification limit, enabling corrective action, supplier trending, and root-cause investigation. It also supports manufacturers who impose stricter internal action limits, improves statistical confidence in pass/fail decisions near thresholds, and provides defensible data during regulatory inspections or supply chain disputes.
Which standards govern DEG residue testing and LOQ validation?
Compendial monographs from USP, Ph. Eur., and ChP define the impurity limits and chromatographic procedures for glycerin and related glycols. ICH Q2(R2) governs analytical procedure validation, including LOQ determination. Laboratory competence is verified through accreditation to ISO/IEC 17025, and product-specific requirements may reference frameworks such as EN 71 for toy materials.
What sample quantity and container are required for submission?
Typical submission requirements are 10 to 50 g or 10 to 50 mL of sample in a clean, tightly sealed glass container with a lined cap. Samples should be protected from moisture uptake and contamination during transport and shipped at ambient temperature unless stability considerations dictate otherwise. Homogeneous liquid samples are preferred; semi-solid and finished product matrices may require additional preparation and should be discussed with the laboratory in advance.
What is the typical turnaround time?
Routine DEG quantification using validated methods is generally completed within 5 to 10 working days after sample receipt. Expedited services may be available for urgent investigations. Full method validation for a new matrix, including LOQ determination, requires additional time because it involves multi-level spiking, replicate precision studies, and formal documentation.